Eight-year follow-up of airway hyperresponsiveness in patients with primary Sjogren's syndrome

被引:9
作者
Ludviksdottir, Dora [1 ,2 ]
Valtysdottir, Sigridur Th. [3 ]
Hedenstrom, Hans [4 ]
Hallgren, Roger [5 ]
Gudbjornsson, Bjorn [3 ,6 ]
机构
[1] Univ Hosp, Dept Allergy, Reykjavik, Iceland
[2] Univ Hosp, Dept Resp Med, Reykjavik, Iceland
[3] Univ Hosp, Ctr Rheumatol Res, Reykjavik, Iceland
[4] Univ Uppsala Hosp, Akad Sjukhuset, Dept Clin Physiol, Uppsala, Sweden
[5] Univ Uppsala Hosp, Akad Sjukhuset, Dept Med Sci, Uppsala, Sweden
[6] Univ Iceland, Fac Med, Reykjavik, Iceland
关键词
Airway hyperresponsiveness; follow-up; lung function; Sjogren's syndrome; LUNG-FUNCTION TESTS; PULMONARY-FUNCTION; BRONCHIAL HYPERRESPONSIVENESS; REGRESSION EQUATIONS; SMOKING VARIABLES; REFERENCE VALUES; INVOLVEMENT; DISEASE; ASTHMA; RESPONSIVENESS;
D O I
10.1080/03009734.2016.1239663
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate in a longitudinal study the influence of airway hyperresponsiveness (AHR) on lung function in patients with primary Sjogren's syndrome (pSS). Methods: Lung function was studied over an eight-year period in 15 patients who fulfilled the Copenhagen criteria for primary Sjogren's syndrome and who were covered in our earlier published study on AHR in patients with Sjogren's syndrome. Standard spirometry and measurements of lung volumes, diffusing capacity (DLCO), and AHR to methacholine were performed. Results: A significant decline over time was found in total lung capacity (TLC), vital capacity (VC), forced vital capacity (FVC), functional residual capacity (FRC), and expiratory midflows (FEF50). A sign of small airway obstruction (decrease in FEF50) at entry correlated with VC at follow-up (r = .8, P < .003), and the individual change in FEF50 during the observation period correlated with the individual change in VC (r = .6, P < .05). Six patients had increased AHR, and three of them had decreased DLCO. Six of the patients progressively reduced DLCO over time, and five of them had spirometric signs of increased small airway obstruction. Conclusions: During this eight-year follow-up we observed that one-third of the patients with pSS developed a significant reduction in lung function. Our findings suggest that small airways obstruction and AHR are associated with reduction of VC and development of impaired DLCO as a sign of interstitial lung disease in this group of patients.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 50 条
  • [31] Interferon-γ Is Increased in Patients with Primary Sjogren's Syndrome and Raynaud's Phenomenon
    Willeke, Peter
    Schlueter, Bernhard
    Schotte, Heiko
    Domschke, Wolfram
    Gaubitz, Markus
    Becker, Heidemarie
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 39 (03) : 197 - 202
  • [32] Adherence of obstructive sleep apnoea syndrome patients to positive airway pressure therapy-10-year follow-up
    Genzor, Samuel
    Prasko, Jan
    Vanek, Jakub
    Asswad, Amjad Ghazal
    Nadjarpour, Shayan
    Sova, Milan
    BIOMEDICAL PAPERS-OLOMOUC, 2022, 166 (04): : 441 - 446
  • [33] Seronegative primary Sjogren's syndrome, a distinct subtype of primary Sjogren's syndrome in Chinese patients
    Lan, Jingying
    Deng, Chaoqiong
    Huang, Heqing
    Rao, Peishi
    Chen, Yangchun
    Shi, Yingying
    Chen, Jie
    Shi, Guixiu
    Liu, Yuan
    Chen, Shiju
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [34] Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjogren's syndrome
    Kakugawa, Tomoyuki
    Sakamoto, Noriho
    Ishimoto, Hiroshi
    Shimizu, Toshimasa
    Nakamura, Hideki
    Nawata, Aya
    Ito, Chiyo
    Sato, Shuntaro
    Hanaka, Tetsuya
    Oda, Keishi
    Kido, Takashi
    Miyamura, Takuto
    Nakashima, Shota
    Aoki, Takatoshi
    Nakamichi, Seiko
    Obase, Yasushi
    Saito, Kazuyoshi
    Yatera, Kazuhiro
    Ishimatsu, Yuji
    Nakayama, Toshiyuki
    Korogi, Yukunori
    Kawakami, Atsushi
    Tanaka, Yoshiya
    Mukae, Hiroshi
    RESPIRATORY MEDICINE, 2018, 137 : 95 - 102
  • [35] 3-Year Follow-Up of Patients With Coronary Artery Spasm as Cause of Acute Coronary Syndrome The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study Follow-Up
    Ong, Peter
    Athanasiadis, Anastasios
    Borgulya, Gabor
    Voehringer, Matthias
    Sechtem, Udo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (02) : 147 - 152
  • [36] Risk of asthma in patients with primary Sjogren's syndrome: a retrospective cohort study
    Shen, Te-Chun
    Chen, Hsuan-Ju
    Wei, Chang-Ching
    Chen, Chia-Hung
    Tu, Chih-Yen
    Hsia, Te-Chun
    Shih, Chuen-Ming
    Hsu, Wu-Huei
    Sung, Fung-Chang
    Bau, Da-Tian
    BMC PULMONARY MEDICINE, 2016, 16
  • [37] Use of methotrexate in patients with systemic lupus erythematosus and primary Sjogren's syndrome
    Winzer, M.
    Aringer, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S156 - S159
  • [38] Three-year follow-up in patients with acute coronary syndrome and normal coronary angiography
    Sun, Jing
    Zhang, Weihua
    Zeng, Qiang
    Dong, Shengyong
    Sun, Xiaonan
    CORONARY ARTERY DISEASE, 2012, 23 (03) : 162 - 166
  • [39] Metabolic syndrome in Italian patients with bipolar disorder: A 2-year follow-up study
    Salvi, Virginio
    D'Ambrosio, Virginia
    Bogetto, Filippo
    Maina, Giuseppe
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 136 (03) : 599 - 603
  • [40] One year follow-up of patients with screen-detected metabolic syndrome in primary care: an observational study
    den Engelsen, Corine
    Gorter, Kees J.
    Salome, Philippe L.
    Rutten, Guy E.
    FAMILY PRACTICE, 2013, 30 (01) : 40 - 47